Legal Representation
Attorney
Thilo C. Agthe
USPTO Deadlines
Next Renewal Deadline
1492 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-08-08)
Due Date
August 08, 2029
Grace Period Ends
February 08, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
45 eventsDate | Code | Type | Description |
---|---|---|---|
Aug 8, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Aug 8, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Jul 4, 2023 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Jul 3, 2023 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Jun 7, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Jun 6, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED |
Jun 6, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
May 30, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
May 30, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
May 30, 2023 | EXT4 | S | SOU EXTENSION 4 FILED |
May 30, 2023 | IUAF | S | USE AMENDMENT FILED |
Feb 4, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Feb 3, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED |
Jan 31, 2023 | PROA | I | TEAS PETITION TO REVIVE RECEIVED |
Jan 31, 2023 | PETG | O | PETITION TO REVIVE-GRANTED |
Jan 31, 2023 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION |
Jan 31, 2023 | NREV | E | NOTICE OF REVIVAL - E-MAILED |
Jan 30, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Jan 30, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Dec 29, 2022 | EXT3 | S | SOU EXTENSION 3 FILED |
Aug 6, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Aug 5, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED |
Aug 4, 2022 | PROA | I | TEAS PETITION TO REVIVE RECEIVED |
Aug 4, 2022 | PETG | O | PETITION TO REVIVE-GRANTED |
Aug 4, 2022 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION |
Aug 4, 2022 | NREV | E | NOTICE OF REVIVAL - E-MAILED |
Aug 1, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
Aug 1, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Jun 29, 2022 | EXT2 | S | SOU EXTENSION 2 FILED |
Feb 18, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Feb 17, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED |
Feb 16, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Jan 13, 2022 | PROA | I | TEAS PETITION TO REVIVE RECEIVED |
Jan 13, 2022 | PETG | O | PETITION TO REVIVE-GRANTED |
Jan 13, 2022 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION |
Jan 13, 2022 | NREV | E | NOTICE OF REVIVAL - E-MAILED |
Dec 29, 2021 | EXT1 | S | SOU EXTENSION 1 FILED |
Jun 29, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
May 4, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION |
May 4, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Apr 14, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Mar 30, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
Mar 30, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Dec 23, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Nov 2, 2020 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances for the treatment of a wide range of acute and chronic inflammatory conditions
First Use Anywhere:
May 4, 2023
First Use in Commerce:
May 4, 2023
Classification
International Classes
005